tretinoin and Anemia--Sideroblastic

tretinoin has been researched along with Anemia--Sideroblastic* in 1 studies

Trials

1 trial(s) available for tretinoin and Anemia--Sideroblastic

ArticleYear
Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndrome.
    Lancet (London, England), 1987, Apr-04, Volume: 1, Issue:8536

    A randomised therapeutic trial of 13-cis-retinoic acid was carried out in 70 patients with myelodysplastic syndrome having 5% or fewer marrow blast cells. Among non-sideroblastic patients the 1-year survival in the treated group was 77%, compared with 36% in the control group. There were too few deaths among patients with sideroblastic anaemia to allow any effect of therapy on survival to be evaluated.

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Sideroblastic; Clinical Trials as Topic; Female; Humans; Isomerism; Isotretinoin; Male; Middle Aged; Myelodysplastic Syndromes; Random Allocation; Tretinoin

1987